Accurate, balanced evidence-based information about medicines
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR December 2005 NPS RADAR>Full Issue>Health Professional Publication | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Anastrozole (Arimidex) for breast cancer in postmenopausal women NPS RADAR>Review>Health Professional Publication | Reports on PBS listing extension of anastrozole to include all postmenopausal women with hormone-dependent early breast cancer and compares anastrozole with tamoxifen. |
| Atorvastatin (Lipitor) for the management of lipid disorders NPS RADAR>Review>Health Professional Publication | Reviews use of atorvastatin for hyperlipidaemia, including comparison with simvastatin and pravastatin. Risk of myopathy and rhabdomyolysis is similar to that from other statins. |
| Buprenorphine transdermal patches (Norspan) for chronic severe pain NPS RADAR>Review>Health Professional Publication | Reviews use of buprenorphine skin patches for chronic severe non-cancer pain, including adverse effects, contraindications, and treatment of overdose. |
| Metformin/glibenclamide (Glucovance) for type 2 diabetes mellitus NPS RADAR>Review>Health Professional Publication | Reviews use of metformin/glibenclamide combination tablets for type 2 diabetes mellitus, including comparison with co-administered drugs and risk of hypoglycaemia. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2005-12-01 00:00:00
The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of clinical circumstances of each patient.